Bonraybio Co., Ltd. (TPE:6955)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
171.50
+0.50 (0.29%)
At close: Feb 11, 2026
Market Cap4.25B +51.9%
Revenue (ttm)287.10M +36.0%
Net Income96.28M +74.0%
EPS3.92 +60.2%
Shares Out24.80M
PE Ratio43.73
Forward PEn/a
Dividend1.30 (0.76%)
Ex-Dividend DateMar 27, 2025
Volume15,100
Average Volume13,669
Open170.00
Previous Close171.00
Day's Range167.50 - 173.00
52-Week Range104.35 - 186.96
Beta0.08
RSI58.35
Earnings DateFeb 26, 2026

About Bonraybio

Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was found... [Read more]

Sector Healthcare
Founded 2015
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6955
Full Company Profile

Financial Performance

In 2024, Bonraybio's revenue was 222.88 million, an increase of 39.61% compared to the previous year's 159.64 million. Earnings were 68.37 million, an increase of 165.75%.

Financial Statements